Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Submitted by
admin
on April 6, 2018 - 11:26am
Source:
Xtalks
News Tags:
Amgen
Repatha
outcome-based pricing
drug pricing
patients
Headline:
Is Amgen’s Outcomes-Based Pricing Model for Repatha Benefiting Patients and Payers?
Do Not Allow Advertisers to Use My Personal information
